763 related articles for article (PubMed ID: 31404802)
1. Association between cognitive function and performance on effort based decision making in patients with major depressive disorder treated with Vortioxetine.
Subramaniapillai M; Mansur RB; Zuckerman H; Park C; Lee Y; Iacobucci M; Cao B; Ho R; Lin K; Phan L; McIntyre RS
Compr Psychiatry; 2019 Oct; 94():152113. PubMed ID: 31404802
[TBL] [Abstract][Full Text] [Related]
2. Effort-based decision-making is affected by overweight/obesity in major depressive disorder.
Mansur RB; Subramaniapillai M; Zuckerman H; Park C; Iacobucci M; Lee Y; Tuineag M; Hawco C; Frey BN; Rasgon N; Brietzke E; McIntyre RS
J Affect Disord; 2019 Sep; 256():221-227. PubMed ID: 31181378
[TBL] [Abstract][Full Text] [Related]
3. Motivational deficits in effort-based decision making in individuals with subsyndromal depression, first-episode and remitted depression patients.
Yang XH; Huang J; Zhu CY; Wang YF; Cheung EF; Chan RC; Xie GR
Psychiatry Res; 2014 Dec; 220(3):874-82. PubMed ID: 25262638
[TBL] [Abstract][Full Text] [Related]
4. Randomized, double-blind, placebo-controlled study to assess the efficacy and safety of vortioxetine in Japanese patients with major depressive disorder.
Inoue T; Sasai K; Kitagawa T; Nishimura A; Inada I
Psychiatry Clin Neurosci; 2020 Feb; 74(2):140-148. PubMed ID: 31725942
[TBL] [Abstract][Full Text] [Related]
5. Vortioxetine improves symptomatic and functional outcomes in major depressive disorder: A novel dual outcome measure in depressive disorders.
Christensen MC; Loft H; McIntyre RS
J Affect Disord; 2018 Feb; 227():787-794. PubMed ID: 29689693
[TBL] [Abstract][Full Text] [Related]
6. Diminished caudate and superior temporal gyrus responses to effort-based decision making in patients with first-episode major depressive disorder.
Yang XH; Huang J; Lan Y; Zhu CY; Liu XQ; Wang YF; Cheung EF; Xie GR; Chan RC
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():52-9. PubMed ID: 26192817
[TBL] [Abstract][Full Text] [Related]
7. The Efficacy of Vortioxetine on Anhedonia in Patients With Major Depressive Disorder.
Cao B; Park C; Subramaniapillai M; Lee Y; Iacobucci M; Mansur RB; Zuckerman H; Phan L; McIntyre RS
Front Psychiatry; 2019; 10():17. PubMed ID: 30766492
[No Abstract] [Full Text] [Related]
8. Cognitive-functional relationships in major depressive disorder: Crucial data from a Ukrainian open-label study of vortioxetine versus escitalopram.
Levada OA; Troyan AS
J Affect Disord; 2019 May; 250():114-122. PubMed ID: 30852363
[TBL] [Abstract][Full Text] [Related]
9. Changes in sleep predict changes in depressive symptoms in depressed subjects receiving vortioxetine: An open-label clinical trial.
Cao B; Park C; Rosenblat JD; Chen Y; Iacobucci M; Subramaniapillai M; Mansur RB; Zuckerman H; Lee Y; McIntyre RS
J Psychopharmacol; 2019 Nov; 33(11):1388-1394. PubMed ID: 31530216
[TBL] [Abstract][Full Text] [Related]
10. Effort-based decision-making in major depressive disorder: a translational model of motivational anhedonia.
Treadway MT; Bossaller NA; Shelton RC; Zald DH
J Abnorm Psychol; 2012 Aug; 121(3):553-8. PubMed ID: 22775583
[TBL] [Abstract][Full Text] [Related]
11. Long-term functioning outcomes are predicted by cognitive symptoms in working patients with major depressive disorder treated with vortioxetine: results from the AtWoRC study.
Chokka P; Bougie J; Proulx J; Tvistholm AH; Ettrup A
CNS Spectr; 2019 Dec; 24(6):616-627. PubMed ID: 30802419
[TBL] [Abstract][Full Text] [Related]
12. Treatment effects on residual cognitive symptoms among partially or fully remitted patients with major depressive disorder: A randomized, double-blinded, exploratory study with vortioxetine.
Nierenberg AA; Loft H; Olsen CK
J Affect Disord; 2019 May; 250():35-42. PubMed ID: 30826492
[TBL] [Abstract][Full Text] [Related]
13. Pain and major depressive disorder: Associations with cognitive impairment as measured by the THINC-integrated tool (THINC-it).
Cha DS; Carmona NE; Mansur RB; Lee Y; Park HJ; Rodrigues NB; Subramaniapillai M; Rosenblat JD; Pan Z; Lee JH; Lee J; Almatham F; Alageel A; Shekotikhina M; Zhou AJ; Rong C; Harrison J; McIntyre RS
Scand J Pain; 2017 Apr; 15():62-67. PubMed ID: 28850348
[TBL] [Abstract][Full Text] [Related]
14. Assessment in Work Productivity and the Relationship with Cognitive Symptoms (AtWoRC): primary analysis from a Canadian open-label study of vortioxetine in patients with major depressive disorder (MDD).
Chokka P; Bougie J; Rampakakis E; Proulx J
CNS Spectr; 2019 Jun; 24(3):338-347. PubMed ID: 29792585
[TBL] [Abstract][Full Text] [Related]
15. The cognitive effort expenditure for rewards task (C-EEfRT): A novel measure of willingness to expend cognitive effort.
Lopez-Gamundi P; Wardle MC
Psychol Assess; 2018 Sep; 30(9):1237-1248. PubMed ID: 29620381
[TBL] [Abstract][Full Text] [Related]
16. Worth the 'EEfRT'? The effort expenditure for rewards task as an objective measure of motivation and anhedonia.
Treadway MT; Buckholtz JW; Schwartzman AN; Lambert WE; Zald DH
PLoS One; 2009 Aug; 4(8):e6598. PubMed ID: 19672310
[TBL] [Abstract][Full Text] [Related]
17. The effects of vortioxetine on cognitive dysfunction in patients with inadequate response to current antidepressants in major depressive disorder: A short-term, randomized, double-blind, exploratory study versus escitalopram.
Vieta E; Sluth LB; Olsen CK
J Affect Disord; 2018 Feb; 227():803-809. PubMed ID: 29673132
[TBL] [Abstract][Full Text] [Related]
18. Cost per successfully treated patient for vortioxetine versus duloxetine in adults with major depressive disorder: an analysis of the complete symptoms of depression and functional outcome.
Christensen MC; Munro V
Curr Med Res Opin; 2018 Apr; 34(4):593-600. PubMed ID: 29235884
[TBL] [Abstract][Full Text] [Related]
19. Effects of vortioxetine on functional capacity across different levels of functional impairment in patients with major depressive disorder: a University of California, San Diego Performance-based Skills Assessment (UPSA) analysis.
Jacobson W; Zhong W; Nomikos GG; Christensen MC; Kurre Olsen C; Harvey PD
Curr Med Res Opin; 2020 Jan; 36(1):117-124. PubMed ID: 31422713
[No Abstract] [Full Text] [Related]
20. Inefficient effort allocation and negative symptoms in individuals with schizophrenia.
McCarthy JM; Treadway MT; Bennett ME; Blanchard JJ
Schizophr Res; 2016 Feb; 170(2-3):278-84. PubMed ID: 26763628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
